Longevity Patent Family

A PHARMACEUTICAL COMPOSITION COMPRISING EMPAGLIFLOZIN AND METFORMIN

Source-linked patent metadata for A PHARMACEUTICAL COMPOSITION COMPRISING EMPAGLIFLOZIN AND METFORMIN, including priority, record stage and longevity-topic connections.

Patent-family snapshot

Application publication visible

Family grouping brings related publications for the same invention together, instead of counting every national filing as a separate technology.

Representative publication
EP4808529A1
Earliest priority
November 15, 2023
Latest publication
September 23, 2026
Family publications
1
Patent offices
1
Patent-to-Evidence Translation Map

What is happening in the same scientific field?

These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.

Organizations

Organizations named in this family

Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim SirketiApplicantABDI IBRAHIM ILAC SANAYI VE TICARET ANONIM SIRKETI [TR]Applicant
Longevity context

Topics connected by metadata

Metformin88% metadata match
Knowledge connections

What this family cites

Earlier patent references
0
Scientific and other non-patent references
0
Priority dates represented
2

References show which earlier documents the patent record points to. They do not validate the invention or prove that cited research supports its claims.

Technical classification

How the patent office classifies this invention

No patent classification is available in the retained record.

Verify in the original patent source →